Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

MRI Lesions in the Sacroiliac Joints for Differentiation of Patients with Axial Spondyloarthritis from Postpartum Women, Patients with Disc Herniation, Cleaning Staff, Long Distance Runners and Healthy Persons - A Prospective Cross-sectional Study of 204 Participants.

Seven S, Østergaard M, Morsel-Carlsen L, Sørensen IJ, Bonde B, Thamsborg G, Lykkegaard JJ, Hendricks O, Jørgensen NR, Pedersen SJ.

Arthritis Rheumatol. 2019 Jul 16. doi: 10.1002/art.41037. [Epub ahead of print]

PMID:
31309740
2.

Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.

Glintborg B, Loft AG, Omerovic E, Hendricks O, Linauskas A, Espesen J, Danebod K, Jensen DV, Nordin H, Dalgaard EB, Chrysidis S, Kristensen S, Raun JL, Lindegaard H, Manilo N, Jakobsen SH, Hansen IMJ, Pedersen DD, Sørensen IJ, Andersen LS, Grydehøj J, Mehnert F, Krogh NS, Lund Hetland M.

Ann Rheum Dis. 2019 Jan 23. pii: annrheumdis-2018-214952. doi: 10.1136/annrheumdis-2018-214952. [Epub ahead of print] No abstract available.

PMID:
30674476
3.

Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.

Glintborg B, Loft AG, Omerovic E, Hendricks O, Linauskas A, Espesen J, Danebod K, Jensen DV, Nordin H, Dalgaard EB, Chrysidis S, Kristensen S, Raun JL, Lindegaard H, Manilo N, Jakobsen SH, Hansen IMJ, Dalsgaard Pedersen D, Sørensen IJ, Andersen LS, Grydehøj J, Mehnert F, Krogh NS, Hetland ML.

Ann Rheum Dis. 2018 Dec 20. pii: annrheumdis-2018-214788. doi: 10.1136/annrheumdis-2018-214788. [Epub ahead of print] No abstract available.

PMID:
30573653
4.

Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients.

Secher AE, Glintborg B, Gudbergsen H, Krogh NS, Sørensen IJ, Jensen DV, Christensen R, Skougaard M, Pedersen PL, Hetland ML.

Scand J Rheumatol. 2019 May;48(3):178-184. doi: 10.1080/03009742.2018.1522666. Epub 2018 Nov 16. Erratum in: Scand J Rheumatol. 2019 May;48(3):258.

PMID:
30444168
5.

Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.

Pedersen SJ, Weber U, Said-Nahal R, Sørensen IJ, Loft AG, Kollerup G, Juul L, Frandsen PB, Thamsborg G, Madsen OR, Møller J, Balding L, Jurik AG, Østergaard M.

Scand J Rheumatol. 2019 May;48(3):185-197. doi: 10.1080/03009742.2018.1506822. Epub 2018 Nov 13.

PMID:
30422733
6.

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.

Glintborg B, Loft AG, Omerovic E, Hendricks O, Linauskas A, Espesen J, Danebod K, Jensen DV, Nordin H, Dalgaard EB, Chrysidis S, Kristensen S, Raun JL, Lindegaard H, Manilo N, Jakobsen SH, Hansen IMJ, Dalsgaard Pedersen D, Sørensen IJ, Andersen LS, Grydehøj J, Mehnert F, Krogh NS, Hetland ML.

Ann Rheum Dis. 2019 Feb;78(2):192-200. doi: 10.1136/annrheumdis-2018-213474. Epub 2018 Nov 5.

PMID:
30396903
7.

Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial.

Krabbe S, Sørensen IJ, Jensen B, Møller JM, Balding L, Madsen OR, Lambert RGW, Maksymowych WP, Pedersen SJ, Østergaard M.

RMD Open. 2018 Mar 16;4(1):e000624. doi: 10.1136/rmdopen-2017-000624. eCollection 2018.

8.

Whole-body Magnetic Resonance Imaging in Axial Spondyloarthritis: Reduction of Sacroiliac, Spinal, and Entheseal Inflammation in a Placebo-controlled Trial of Adalimumab.

Krabbe S, Østergaard M, Eshed I, Sørensen IJ, Jensen B, Møller JM, Balding L, Madsen OR, Asmussen K, Eng G, Jørgensen NR, Pedersen SJ.

J Rheumatol. 2018 May;45(5):621-629. doi: 10.3899/jrheum.170408. Epub 2018 Feb 15.

PMID:
29449506
9.

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.

Glintborg B, Kringelbach T, Bolstad N, Warren DJ, Eng G, Sørensen IJ, Loft AG, Hendricks O, Hansen I, Linauskas A, Nordin H, Kristensen S, Lindegaard H, Jensen DV, Goll GL, Høgdall E, Gehin J, Enevold C, Nielsen CH, Krogh NS, Johansen JS, Hetland ML.

Scand J Rheumatol. 2018 Sep;47(5):418-421. doi: 10.1080/03009742.2017.1376110. Epub 2018 Jan 9. No abstract available.

PMID:
29310493
10.

Development and Validation of MRI Sacroiliac Joint Scoring Methods for the Semiaxial Scan Plane Corresponding to the Berlin and SPARCC MRI Scoring Methods, and of a New Global MRI Sacroiliac Joint Method.

Hededal P, Østergaard M, Sørensen IJ, Loft AG, Hindrup JS, Thamsborg G, Asmussen K, Hendricks O, Nørregaard J, Møller JM, Jurik AG, Morsel L, Balding L, Pedersen SJ.

J Rheumatol. 2018 Jan;45(1):70-77. doi: 10.3899/jrheum.161583. Epub 2017 Oct 1.

PMID:
28966208
11.

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.

Glintborg B, Sørensen IJ, Loft AG, Lindegaard H, Linauskas A, Hendricks O, Hansen IMJ, Jensen DV, Manilo N, Espesen J, Klarlund M, Grydehøj J, Dieperink SS, Kristensen S, Olsen JS, Nordin H, Chrysidis S, Dalsgaard Pedersen D, Sørensen MV, Andersen LS, Grøn KL, Krogh NS, Pedersen L, Hetland ML; all departments of rheumatology in Denmark.

Ann Rheum Dis. 2017 Aug;76(8):1426-1431. doi: 10.1136/annrheumdis-2016-210742. Epub 2017 May 4.

PMID:
28473425
12.

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.

Glintborg B, Sørensen IJ, Østergaard M, Dreyer L, Mohamoud AA, Krogh NS, Hendricks O, Andersen LS, Raun JL, Kowalski MR, Danielsen L, Pelck R, Nordin H, Pedersen JK, Kraus DG, Christensen SR, Hansen IM, Esbesen J, Schlemmer A, Loft AG, Al Chaer N, Salomonsen L, Hetland ML.

J Rheumatol. 2017 Jan;44(1):59-69. doi: 10.3899/jrheum.160958. Epub 2016 Dec 1.

PMID:
27909080
13.

Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry.

Hetland ML, Krogh NS, Hørslev-Petersen K, Schiøttz-Christensen B, Sørensen IJ, Dorte Vendelbo J.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S75-S78. Epub 2016 Oct 19.

14.

Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis.

Sepriano A, Landewé R, van der Heijde D, Sieper J, Akkoc N, Brandt J, Braun J, Collantes-Estevez E, Dougados M, Fitzgerald O, Huang F, Gu J, Kirazli Y, Maksymowych WP, Marzo-Ortega H, Olivieri I, Ozgocmen S, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Van den Bosch F, van der Horst-Bruinsma I, Weber U, Wei J, Rudwaleit M; ASAS.

Ann Rheum Dis. 2016 Jun;75(6):1034-42. doi: 10.1136/annrheumdis-2015-208730. Epub 2016 Feb 10.

PMID:
26865599
15.

Magnetic resonance imaging for diagnosing, monitoring and prognostication in psoriatic arthritis.

Poggenborg RP, Sørensen IJ, Pedersen SJ, Østergaard M.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S66-9. Epub 2015 Oct 15. Review.

PMID:
26470678
16.

Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.

Pedersen SJ, Poddubnyy D, Sørensen IJ, Loft AG, Hindrup JS, Thamsborg G, Asmussen K, Hendricks O, Nørregaard J, Piil AD, Møller JM, Jurik AG, Balding L, Lambert RG, Sieper J, Østergaard M.

Arthritis Rheumatol. 2016 Feb;68(2):418-29. doi: 10.1002/art.39434.

17.

Preserved skeletal muscle protein anabolic response to acute exercise and protein intake in well-treated rheumatoid arthritis patients.

Mikkelsen UR, Dideriksen K, Andersen MB, Boesen A, Malmgaard-Clausen NM, Sørensen IJ, Schjerling P, Kjær M, Holm L.

Arthritis Res Ther. 2015 Sep 25;17:271. doi: 10.1186/s13075-015-0758-3.

18.

Magnetic resonance imaging--key to understanding and monitoring disease progression in spondyloarthritis?

Østergaard M, Sørensen IJ.

J Rheumatol. 2015 Jan;42(1):1-4. doi: 10.3899/jrheum.141402. No abstract available.

PMID:
25554801
19.

Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints.

Poggenborg RP, Pedersen SJ, Eshed I, Sørensen IJ, Møller JM, Madsen OR, Thomsen HS, Østergaard M.

Rheumatology (Oxford). 2015 Jun;54(6):1039-49. doi: 10.1093/rheumatology/keu439. Epub 2014 Nov 26.

PMID:
25431482
20.

[Post-partum transient osteoporosis of the hip causing pain].

Svensson AL, Jensen JE, Morsel-Carlsen L, Sørensen IJ.

Ugeskr Laeger. 2014 Jul 14;176(29):V08130508. Danish.

PMID:
25292204
21.

Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination.

Poggenborg RP, Eshed I, Østergaard M, Sørensen IJ, Møller JM, Madsen OR, Pedersen SJ.

Ann Rheum Dis. 2015 May;74(5):823-9. doi: 10.1136/annrheumdis-2013-204239. Epub 2014 Jan 3.

PMID:
24389294
22.

No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial.

Poggenborg RP, Wiell C, Bøyesen P, Boonen A, Bird P, Pedersen SJ, Sørensen IJ, Madsen OR, Slot O, Møller JM, Hasselquist M, Kubassova O, Østergaard M.

Rheumatology (Oxford). 2014 Apr;53(4):746-56. doi: 10.1093/rheumatology/ket426. Epub 2013 Dec 24.

PMID:
24369412
23.

Pattern of bone erosion and bone proliferation in psoriatic arthritis hands: a high-resolution computed tomography and radiography follow-up study during adalimumab therapy.

Poggenborg RP, Bird P, Boonen A, Wiell C, Pedersen SJ, Sørensen IJ, Madsen OR, Slot O, Møller JM, Bøyesen P, Hasselquist M, Østergaard M.

Scand J Rheumatol. 2014;43(3):202-8. doi: 10.3109/03009742.2013.835865. Epub 2013 Dec 19.

PMID:
24354412
24.

Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.

Nordgaard-Lassen I, Dahlerup JF, Belard E, Gerstoft J, Kjeldsen J, Kragballe K, Ravn P, Sørensen IJ, Theede K, Tjellesen L; Danish Society for Gastroenterology.

Dan Med J. 2012 Jul;59(7):C4480.

PMID:
22759856
25.

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.

Pedersen SJ, Sørensen IJ, Lambert RG, Hermann KG, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M.

Arthritis Rheum. 2011 Dec;63(12):3789-800. doi: 10.1002/art.30627.

26.

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.

Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Lambert R, Hansen A, Østergaard M.

Ann Rheum Dis. 2011 Aug;70(8):1375-81. doi: 10.1136/ard.2010.138883. Epub 2011 May 8.

PMID:
21551511
27.

The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Weber U, Wei J, Sieper J.

Ann Rheum Dis. 2011 Jan;70(1):25-31. doi: 10.1136/ard.2010.133645. Epub 2010 Nov 24.

PMID:
21109520
28.

Evidence-based recommendations for treatment with methotrexate in rheumatic disorders.

Madsen OR, Faurschou M, Loft AG, Sørensen IJ, Knudsen JB, Baslund B, Hansen A, Hansen MS, Østergaard M.

Dan Med Bull. 2010 Oct;57(10):A4190.

PMID:
21040680
29.

Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors.

Pedersen SJ, Hetland ML, Sørensen IJ, Ostergaard M, Nielsen HJ, Johansen JS.

Clin Rheumatol. 2010 Nov;29(11):1301-9. doi: 10.1007/s10067-010-1528-x. Epub 2010 Jul 18.

PMID:
20640910
30.

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M.

Ann Rheum Dis. 2010 Jun;69(6):1065-71. doi: 10.1136/ard.2009.111187. Epub 2009 Sep 9.

PMID:
19740906
31.

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.

Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B.

Arthritis Rheum. 2009 Apr;60(4):1187-92. doi: 10.1002/art.24386.

32.

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J.

Ann Rheum Dis. 2009 Jun;68(6):777-83. doi: 10.1136/ard.2009.108233. Epub 2009 Mar 17. Erratum in: Ann Rheum Dis. 2019 Jun;78(6):e59.

PMID:
19297344
33.

Cancer preceding Wegener's granulomatosis: a case-control study.

Faurschou M, Mellemkjaer L, Sorensen IJ, Thomsen BS, Dreyer L, Baslund B.

Rheumatology (Oxford). 2009 Apr;48(4):421-4. doi: 10.1093/rheumatology/kep009. Epub 2009 Feb 12.

PMID:
19213850
34.

[Danish recommendations on treatment of ankylosing spondylitis and spondyloarthritis based on multinational project initiative].

Pedersen SJ, Madsen OR, Erlendsson J, Schiøttz-Christensen B, Sørensen IJ, Andersen LS, Ostergaard M.

Ugeskr Laeger. 2008 Dec 1;170(49):4044-50. Danish.

PMID:
19087747
35.

Re-activation of bovine tuberculosis in a patient treated with infliximab.

Larsen MV, Sørensen IJ, Thomsen VØ, Ravn P.

Eur Respir J. 2008 Jul;32(1):229-31. doi: 10.1183/09031936.00125607.

36.

[Rheumatology in 2008. The Danish Society of Rheumatology].

Madsen OR, Sørensen IJ, Kjaer M, Schiøttz-Christensen B, Bliddal H, Østergaard M; Dansk Reumatologisk Selskab.

Ugeskr Laeger. 2008 Mar 17;170(12):1054. Danish. No abstract available.

PMID:
18397672
37.

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N, Baslund B.

J Rheumatol. 2008 Jan;35(1):100-5. Epub 2007 Oct 15.

PMID:
17937462
38.

[Simultaneous presence of Takayasu's arteritis and factor V Leiden thrombophilia].

Jørgensen J, Sørensen IJ, Jensen BA.

Ugeskr Laeger. 2005 Jan 31;167(5):528-9. Danish. No abstract available.

PMID:
15745180
39.

Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.

Sørensen IJ, Holm Nielsen E, Schrøder L, Voss A, Horváth L, Svehag SE.

J Clin Immunol. 2000 Nov;20(6):408-15.

PMID:
11202230
40.

[Dengue fever].

Sørensen IJ, Pedersen SS.

Ugeskr Laeger. 2000 Sep 18;162(38):5089-91. Danish.

PMID:
11014142
41.

Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery.

Brix-Christensen V, Tønnesen E, Sørensen IJ, Bilfinger TV, Sanchez RG, Stefano GB.

Acta Anaesthesiol Scand. 1998 Jan;42(1):63-70.

PMID:
9527747
42.

Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH.

Danielsen B, Sørensen IJ, Nybo M, Nielsen EH, Kaplan B, Svehag SE.

Biochim Biophys Acta. 1997 Apr 25;1339(1):73-8.

PMID:
9165101
43.

Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase.

Sørensen IJ, Nielsen EH, Andersen O, Danielsen B, Svehag SE.

Scand J Immunol. 1996 Oct;44(4):401-7.

PMID:
8845035
44.

Native human serum amyloid P component is a single pentamer.

Sørensen IJ, Andersen O, Nielsen EH, Svehag SE.

Scand J Immunol. 1995 Mar;41(3):263-7.

PMID:
7871385
45.

Multiple isoforms of the human pentraxin serum amyloid P component.

Sørensen IJ, Andersen O, Nielsen EH, Svehag SE.

Int Arch Allergy Immunol. 1995 Jan;106(1):25-31.

PMID:
7812162
47.

[Serum electrolytes and drug therapy of patients admitted to a geriatric department].

Sørensen IJ, Matzen LE.

Ugeskr Laeger. 1993 Nov 29;155(48):3921-4. Danish.

PMID:
8273199
48.

Family studies of complement C4 and HLA in man.

Bruun-Petersen G, Lamm LU, Sørensen IJ, Buskjaer L, Mortensen JP.

Hum Genet. 1981;58(3):260-7.

PMID:
6948763
49.

Genetic studies of complement C4 in man.

Petersen GB, Sørensen IJ, Buskjaer L, Lamm LU.

Hum Genet. 1979;53(1):31-6.

PMID:
535900

Supplemental Content

Loading ...
Support Center